ClinicalTrials.gov
ClinicalTrials.gov Menu

Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients (VANCS II)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01718613
Recruitment Status : Completed
First Posted : October 31, 2012
Last Update Posted : May 18, 2018
Sponsor:
Information provided by (Responsible Party):
Cristiane Maciel Zambolim, Instituto do Cancer do Estado de São Paulo

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2014
  Actual Study Completion Date : May 2018